Cargando…

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs

SIMPLE SUMMARY: Although serum tumour markers offer an uncomplicated, non-invasive examination method and possible therapeutic options, they are still rarely used in veterinary medicine. Our marker of interest, the Ki-67 protein, can only be detected in the active phases of the cell cycle. Therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estaller, Annkathrin, Kessler, Martin, Wehrend, Axel, Hirschberger, Johannes, Neumann, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138135/ https://www.ncbi.nlm.nih.gov/pubmed/35625109 http://dx.doi.org/10.3390/ani12101263

Ejemplares similares

Investigation of serum survivin in dogs suffering from cancer: a multicenter study
por: Estaller, Annkathrin, et al.
Publicado: (2021)

An Immunohistochemical Study Showing Ki-67 as an Analytical Marker in Oral Malignant and Premalignant Lesions
por: Dash, Kailash C, et al.
Publicado: (2020)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

Malignant Pleural Mesothelioma—Does Ki67 Make the Grade?
por: Prall, Owen W.J.
Publicado: (2021)

Ki‐67/CD3 ratio in the diagnosis of chronic inflammatory enteropathy in dogs
por: Karlovits, Sonja, et al.
Publicado: (2019)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy
por: FU, Dah-Renn, et al.
Publicado: (2014)

Clinical validity and clinical utility of Ki67 in early breast cancer
por: Kreipe, Hans, et al.
Publicado: (2022)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Expression of p-16, Ki-67 and p-53 markers in dysplastic and malignant lesions of the oral cavity and oropharynx
por: Yadav, Priyanka, et al.
Publicado: (2019)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

Ki-67 is a prognostic marker for hormone receptor positive tumors
por: Pérez-López, M. E., et al.
Publicado: (2016)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

Evaluation of diagnostic utility of imprint cytology in paediatric renal tumours with special references to Ki 67 proliferative marker
por: Maity, Namrata, et al.
Publicado: (2018)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Ki67 is a biological marker of malignant risk of gastrointestinal stromal tumors: A systematic review and meta-analysis
por: Zhou, Yu, et al.
Publicado: (2017)

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor
por: Bologna-Molina, Ronell, et al.
Publicado: (2013)

Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification
por: Nielsen, Ljudmilla A. G., et al.
Publicado: (2018)

Ki-67 labeling index as a prognostic marker in advanced stomach cancer
por: Seo, Sang Hyuk, et al.
Publicado: (2019)

Characterization of Cytokines and Proliferation Marker Ki67 in Cleft Affected Lip Tissue
por: Pilmane, Mara, et al.
Publicado: (2019)

Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma
por: Xu, Guangda, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Assessment of Expression of Ki-67 in Benign and Malignant Prostatic Lesions among Sudanese Patients
por: Mohamed, Albasheer Abdelmalik, et al.
Publicado: (2018)

Osteopontin, GLUT1 and Ki‐67 expression in malignant peritoneal mesothelioma: prognostic implications
por: Liu, Yingying, et al.
Publicado: (2021)

Spectrum of meningioma with special reference to prognostic utility of ER,PR and Ki67 expression
por: Mukhopadhyay, Madhumita, et al.
Publicado: (2017)

Ki-67 acts as a biological surfactant to disperse mitotic chromosomes
por: Cuylen, Sara, et al.
Publicado: (2016)

Immunolocalization of Ki-67 in different periodontal conditions
por: Preethi, Penubolu Lakshmi, et al.
Publicado: (2014)

Characterization of Cytokines and Proliferation Marker Ki-67 in Chronic Rhinosinusitis with Recurring Nasal Polyps
por: Viksne, Rudolfs Janis, et al.
Publicado: (2022)

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
por: Jing, Yue, et al.
Publicado: (2019)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Low correlation between Ki67 assessed by qRT-PCR in Oncotype Dx score and Ki67 assessed by Immunohistochemistry
por: Selmani, Zohair, et al.
Publicado: (2022)

Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
por: Choi, Soon Bo, et al.
Publicado: (2022)

Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer
por: Yuan, Jing Ping, et al.
Publicado: (2015)

ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling
por: Barricelli, Barbara Rita, et al.
Publicado: (2019)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Boyaci, Ceren, et al.
Publicado: (2021)

Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_req46echel2hffb0nimh3jli85